B-CELL

Clinical trials for B-CELL explained in plain language.

Never miss a new study

Get alerted when new B-CELL trials appear

Sign up with your email to follow new studies for B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New drug cocktail shows promise for Hard-to-Treat lymphoma

Disease control Ongoing

This early-stage study is testing a combination of three drugs—obinutuzumab, venetoclax, and lenalidomide—in people whose B-cell non-Hodgkin lymphoma has come back or stopped responding to treatment. The main goal is to find the safest dose and see how well the drugs work togethe…

Matched conditions: B-CELL

Phase: PHASE1 • Sponsor: Beth Christian • Aim: Disease control

Last updated May 17, 2026 02:36 UTC

B-CELL

Get alerted when new B-CELL trials appear

New drug cocktail shows promise for Hard-to-Treat lymphoma